Immunocore Statistics Share Statistics Immunocore has 50.18M
shares outstanding. The number of shares has increased by 0.33%
in one year.
Shares Outstanding 50.18M Shares Change (YoY) 0.33% Shares Change (QoQ) 0.24% Owned by Institutions (%) 95.63% Shares Floating 48.67M Failed to Deliver (FTD) Shares 1,939 FTD / Avg. Volume 0.48%
Short Selling Information The latest short interest is 8.44M, so 16.8% of the outstanding
shares have been sold short.
Short Interest 8.44M Short % of Shares Out 16.8% Short % of Float 23.18% Short Ratio (days to cover) 30.67
Valuation Ratios The PE ratio is -28.87 and the forward
PE ratio is -36.24.
Immunocore's PEG ratio is
2.97.
PE Ratio -28.87 Forward PE -36.24 PS Ratio 4.75 Forward PS 3.8 PB Ratio 4.09 P/FCF Ratio 70.6 PEG Ratio 2.97
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Immunocore.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.38,
with a Debt / Equity ratio of 1.2.
Current Ratio 4.38 Quick Ratio 4.36 Debt / Equity 1.2 Debt / EBITDA -6.14 Debt / FCF 20.72 Interest Coverage -3.74
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $629.21K Profits Per Employee $-103.62K Employee Count 493 Asset Turnover 0.31 Inventory Turnover 0.5
Taxes Income Tax -1.85M Effective Tax Rate 3.49%
Stock Price Statistics The stock price has increased by -15.23% in the
last 52 weeks. The beta is 0.78, so Immunocore's
price volatility has been higher than the market average.
Beta 0.78 52-Week Price Change -15.23% 50-Day Moving Average 34.29 200-Day Moving Average 31.31 Relative Strength Index (RSI) 35.8 Average Volume (20 Days) 403,541
Income Statement In the last 12 months, Immunocore had revenue of 310.2M
and earned -51.09M
in profits. Earnings per share was -1.02.
Revenue 310.2M Gross Profit 307.47M Operating Income -70.46M Net Income -51.09M EBITDA -70.46M EBIT -71.78M Earnings Per Share (EPS) -1.02
Full Income Statement Balance Sheet The company has 455.73M in cash and 432.72M in
debt, giving a net cash position of 23.01M.
Cash & Cash Equivalents 455.73M Total Debt 432.72M Net Cash 23.01M Retained Earnings -795.76M Total Assets 1.08B Working Capital 832.22M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 26.06M
and capital expenditures -5.17M, giving a free cash flow of 20.89M.
Operating Cash Flow 26.06M Capital Expenditures -5.17M Free Cash Flow 20.89M FCF Per Share 0.42
Full Cash Flow Statement Margins Gross margin is 99.12%, with operating and profit margins of -22.71% and -16.47%.
Gross Margin 99.12% Operating Margin -22.71% Pretax Margin -17.07% Profit Margin -16.47% EBITDA Margin -22.71% EBIT Margin -22.71% FCF Margin 6.73%
